Company Labormed-Pharma Sa with Fiscal Code 22718452
recorded a turnover of 2024 of
46.702.530,
with a net profit of
5.112.568
and having an average number of employees of
229.
The company operates in the field of Fabricarea preparatelor farmaceutice having the NACE code 2120.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Labormed-Pharma Sa
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
29.094.247
33.095.963
35.990.799
31.007.777
37.467.736
37.107.409
35.135.559
42.004.082
51.780.694
46.702.530
Total Income - EUR
31.844.147
33.548.919
35.302.248
31.998.000
46.992.842
37.766.696
34.247.032
43.231.517
54.324.005
53.518.640
Total Expenses - EUR
33.893.946
30.612.467
32.008.265
25.241.296
41.588.770
34.059.718
28.300.936
34.080.028
41.012.792
47.159.237
Gross Profit/Loss - EUR
-2.049.799
2.936.452
3.293.983
6.756.703
5.404.072
3.706.978
5.946.096
9.151.489
13.311.213
6.359.403
Net Profit/Loss - EUR
-2.049.799
2.936.452
3.052.017
6.756.703
5.404.072
3.706.978
5.946.096
8.851.284
11.409.517
5.112.568
Employees
239
251
275
293
309
296
255
221
221
229
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -9.3%, from 51.780.694 euro in the year 2023, to 46.702.530 euro in 2024.
The Net Profit decreased by -6.233.184 euro, from 11.409.517 euro in 2023, to 5.112.568 in the last year.
Check the financial reports for the company - Labormed-Pharma Sa
Financial Rating - LABORMED-PHARMA SA
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Labormed-Pharma Sa
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Labormed-Pharma Sa
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Labormed-Pharma Sa
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Labormed-Pharma Sa - CUI 22718452
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
37.201.544
40.181.280
41.249.384
40.915.547
31.193.585
25.767.469
26.006.513
24.584.721
23.556.444
26.587.972
Current Assets
16.681.191
17.537.865
17.180.771
19.635.655
33.281.147
34.513.613
38.577.094
52.967.014
65.784.430
53.530.759
Inventories
4.948.046
5.490.502
4.692.529
5.755.044
6.707.765
9.386.334
5.379.242
6.472.176
6.040.291
8.506.555
Receivables
11.109.407
11.379.399
7.217.452
13.749.705
26.010.982
25.005.998
31.030.666
44.949.402
59.031.683
43.073.873
Cash
623.737
667.964
5.270.790
130.905
562.399
121.281
2.167.185
1.545.436
712.456
1.950.330
Shareholders Funds
25.407.128
28.084.462
39.244.899
45.664.883
50.184.603
52.940.200
60.077.919
69.115.596
80.315.524
71.812.907
Social Capital
137.449.944
45.146.967
52.966.660
51.994.628
50.987.693
50.021.087
48.911.822
49.063.571
48.914.788
48.641.417
Debts
16.014.197
23.239.538
12.525.280
14.148.356
13.666.777
6.317.701
3.800.118
7.761.656
8.260.396
7.447.225
Income in Advance
0
0
0
15.766
3.204
381.425
197.951
94.458
64.843
49.135
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"2120 - 2120"
CAEN Financial Year
2120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
53.530.759 euro in 2024 which includes Inventories of
8.506.555 euro, Receivables of
43.073.873 euro and cash availability of
1.950.330 euro.
The company's Equity was valued at
71.812.907 euro, while total Liabilities amounted to
7.447.225 euro.
Equity decreased by -8.053.755 euro, from 80.315.524 euro in 2023, to 71.812.907 in 2024.
The Debt Ratio was 9.4% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Labormed-Pharma Sa